NYSE · CHEMICALS & ALLIED PRODUCTS · LARGE CAP
Chemours Co. CC
13 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$5.8B
▲ 0.4% vs FY2024
EPS · FY25
$-2.57
Dividend / sh · FY25
$0.51
Payout · FY25
-20%
ROE · FY25
-94.0%
Net margin · FY25
-6.6%
Dividend coverage
-5.0×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 5.8B
Revenue, FY2025 · full 13-year series below
Revenue
Net income
The company lost 7 cents on every revenue dollar this year.
Per share
USD -2.57
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
-94.0%
Return on equity, FY2025
ROE
Operating margin-4.8%
Net margin-6.6%
Return on assets-5.2%
Each USD of equity lost 94 cents this year.
Returned to shareholders
USD 78.0M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 78.0M
Net buybacks—
Share of profit-20.2%
Consecutive raises—
USD 78.0M in dividends went back to shareholders in a year without profit.
Growth
+3.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−5.3%
+3.2%
+0.2%
Dividend / share
−20.0%
−12.5%
−1.2%
Returned to shareholders
−49.3%
−13.8%
−2.9%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.15B
Shares outstanding, FY2025
Change, 5 years−9.1%
Change, 10 years−17.2%
The share count shrank 9% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 7.4B
total assets, end of FY2025
Total assetsUSD 7.4B
EquityUSD 250.0M
CashUSD 670.0M
Gross debtUSD 4.1B
Net debtUSD 3.5B
Current ratio1.78×
Net debt stands at 1388% of equity.
History
13 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
Revenue $B
5.8
5.8
6.1
6.8
6.3
5.0
5.5
6.6
6.2
5.4
5.7
6.4
6.9
Operating income $B
−0.3
0.1
−0.3
0.7
0.7
0.2
−0.1
1.2
0.9
−0.0
−0.2
0.6
0.6
EBITDA $B
0.1
0.4
−0.0
1.0
1.0
0.5
0.2
1.4
1.2
0.3
0.1
0.8
0.8
Income tax $B
0.1
0.0
−0.1
0.2
0.1
−0.0
−0.1
0.2
0.2
−0.0
−0.1
0.1
0.2
Net income $B
−0.4
0.1
−0.3
0.6
0.6
0.2
−0.1
1.0
0.7
0.0
−0.1
0.4
0.4
EPS, diluted $
−2.57
0.46
−1.70
3.65
3.60
1.32
−0.32
5.45
3.91
0.04
−0.50
2.21
2.34
Dividend / sh $
0.51
1.00
1.00
1.00
1.00
1.00
1.00
0.67
0.29
0.12
0.58
0.00
·
Payout %
−20
214
−59
27
27
75
−315
15
3
314
−117
0
0
ROE %
−94.0
10.7
−27.7
52.8
64.2
29.2
−6.1
106.2
155.4
6.2
−4.7
10.9
·
Shares out B
0.15
0.15
0.15
0.15
0.16
0.16
0.16
0.17
0.18
0.18
0.18
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
50 of 50
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed